WeVote
Log In

Bill

MD

Bill

A 4327

Revises statutory definition of "elevated blood lead level."

2024-2025 Regular Session Introduced by Margie Donlon and 2 co-sponsors

New Jersey revises its definition of elevated blood lead levels, altering the threshold triggering public health intervention and case identification across the state.

Reported out of Assembly Committee with Amendments, 2nd Reading
#health #humansvcs
0
WeVote Research Nonpartisan
Bill Summary · A 4327

Legislative bill overview

Bill A 4327 revises New Jersey's statutory definition of "elevated blood lead level" (EBLL), the threshold at which lead exposure in blood is considered a public health concern requiring intervention. The bill modifies existing state law that currently defines EBLL based on CDC guidelines, though the specific new definition is not detailed in the available action history. This change would affect how cases are identified, reported, and treated across the state's public health system.

Why is this important

Lead exposure, particularly in children, causes irreversible neurological damage affecting cognitive development, academic performance, and long-term outcomes. Revising the EBLL definition directly determines which individuals are flagged for medical intervention, case management, and environmental remediation—making this a significant public health policy decision that affects screening practices, resource allocation, and individual treatment decisions across New Jersey's health departments and healthcare providers.

Potential points of contention

  • Threshold specificity: Whether the revised definition raises or lowers the EBLL threshold, it will determine who receives intervention; lowering thresholds increases identified cases and costs, while raising them may leave some exposed individuals untreated
  • Alignment with federal guidance: Disagreement may exist over whether New Jersey should deviate from CDC standards, which were recently lowered (2021) to 3.5 µg/dL from 5 µg/dL
  • Implementation and resource burden: Changes require updates to screening protocols, reporting systems, and treatment infrastructure; unclear funding mechanisms may create implementation challenges for local health departments

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.